OWL Metabolomics will be present at EASL Congress 2023, from the 21st to the 24th of June in Vienna. This event represents an invaluable opportunity for experts to delve into the latest developments and innovations in hepatology, which fits perfectly with our background focused on metabolomics research in liver diseases.
Our team of experts will be on hand at our booth #BT1 in the Biotech Village to discuss howwe can become your trusted full-service metabolomics provider for all your research needs in liver diseases and beyond:
As pioneers in medical breakthroughs for non-alcoholic fatty liver disease (NAFLD), we have developed the innovative OWLiver® test. This revolutionary, non-invasive diagnostic tool is based on a simple blood test and utilizes metabolomics to provide a comprehensive diagnosis of the stage of the disease.
Our OWLiver® is based on the measurement of metabolites reflecting the extent of liver fat, inflammation, and stage of fibrosis. By replacing invasive procedures with simple blood tests, we’re transforming the way liver diseases are diagnosed and managed.
Want to ensure you get time to speak with our experts? Pre-book a meeting by reaching out to us at email@example.com. We’d love to discuss your needs and how our innovative tools and expertise can aid in advancing your research or clinical practice.
At OWL Metabolomics, we believe in the power of metabolomics to help us shape together future of medicine. We’re looking forward to discussing our transformative approach with you at the EASL Congress 2023.
For more in-depth information about our services, please visit our website.